Results 161 to 170 of about 397,949 (324)

Liquid Biopsies in Head and Neck Cancers: Recent Developments Across Biofluids, Analytes, and Molecular Features

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Head and neck cancers (HNCs) are too often diagnosed at advanced stages when outcomes are poor. Additionally, robust tools for the early detection of recurrence remain elusive. These gaps drive interest in so‐called liquid biopsy approaches for HNC detection, prognostication, and surveillance.
Patricia J. Brooks, Scott V. Bratman
wiley   +1 more source

Mortality of Laryngeal Cancer before and during the COVID-19 Pandemic

open access: yesCOVID
(1) Background: The interplay between coronavirus disease 2019 (COVID-19) and laryngeal cancer represents a substantial challenge for both patients and healthcare.
Riccardo Nocini   +2 more
doaj   +1 more source

Oncological Impact of Surgical Margin Status After Transoral Laser Microsurgery for Early Glottic Cancer

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Transoral laser microsurgery is a well‐established treatment for early glottic cancer. However, managing patients with close/positive margins remains debated. This study analyzes the relationship between resection margins and oncologic outcomes.
Sae Hatomi   +4 more
wiley   +1 more source

Poorly differentiated neuroendocrine carcinoma originating in the subglottic larynx: A case report with imm unohistochemical study

open access: yesClinical Case Reports
Key Clinical Message Laryngeal neuroendocrine carcinomas are the most common non‐squamous neoplasm of the larynx. Due to the rarity of the tumor, pathological diagnosis should be confirmed by immunohistochemistry.
Mahboobe Asadi   +3 more
doaj   +1 more source

Safety and Efficacy Findings From a Phase Ib/II Study of ASP‐1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

open access: yesHead &Neck, EarlyView.
ABSTRACT Background ASP‐1929 photoimmunotherapy—cetuximab conjugated to IRDye 700DX and red light (690 nm) for localized drug activation—results in rapid, selective cell killing. Methods This phase Ib/II open‐label study evaluated ASP‐1929 photoimmunotherapy plus pembrolizumab in patients with recurrent/metastatic HNSCC (≥ 1 accessible lesion, PD‐L1 ...
David M. Cognetti   +17 more
wiley   +1 more source

Fuel for Recovery: Predicting G‐Tube Dependence in HPV‐Negative Operable HNSCC

open access: yesHead &Neck, EarlyView.
ABSTRACT Background HPV‐negative head and neck squamous cell carcinoma (HNSCC) patients can face prolonged gastrostomy tube (g‐tube) dependence, affecting quality of life and delaying treatment. Existing models lack key health metrics like sarcopenia; this study develops a risk model to enhance preoperative assessment.
Marie‐Michelle McNicoll   +11 more
wiley   +1 more source

Prediction of Recurrent Laryngeal Nerve Invasion in Thyroid Cancer by Ultrasound

open access: yesJournal of Surgical Ultrasound
Assessing recurrent laryngeal nerve invasion is crucial for the accurate staging of thyroid cancer. This, in turn, determines the extent of surgery or whether active surveillance is appropriate.
Jin Hyang Jung, Eunji Kim, Byung Ju Kang
doaj   +1 more source

Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer. [PDF]

open access: yes, 2014
Chudasama, Jessal   +6 more
core   +1 more source

Retroperitoneal extramedullary hematopoietic pseudotumor in ataxia-telangiectasia. [PDF]

open access: yes, 2018
Ataxia-telangiectasia confers a significant increase in the development of several cancer types, most commonly leukemia and lymphoma. However, as the natural history for these patients is evolving and their lifespan is increasing, there is the potential ...
Bateni, Cyrus P   +5 more
core  

Evaluating ChatGPT's recommendations for systematic treatment decisions in recurrent or metastatic head and neck squamous cell carcinoma: Perspectives from experts and junior doctors

open access: yesInternational Journal of Cancer, EarlyView.
What's New? While artificial intelligence (AI) can potentially support clinical decision‐making in recurrent head and neck squamous cell carcinoma (HNSCC), its reliability and accuracy require extensive investigation. Here, the performance of ChatGPT‐4 as a decision‐support tool for staging and treatment planning in HNSCC was assessed. The tool was 83%
Danfang Yan   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy